Below is a summary of the PDL changes that will be effective May 1, All other agents in these classes will retain their current PDL listing.
|
|
- Beverly Pierce
- 5 years ago
- Views:
Transcription
1 STATE OF TENNESSEE DIVISION OF TENNCARE 310 Great Circle Road NASHVILLE, TENNESSEE This notice is to advise you of information regarding the TennCare Pharmacy Program. Please forward or copy the information in this notice to all providers who may be affected by these processing changes. This notice is being sent to notify you of changes for the TennCare pharmacy program. We encourage you to read this notice thoroughly and contact Magellan s Pharmacy Support Center ( ) should you have additional questions. PREFERRED DRUG LIST (PDL) FOR TENNCARE EFFECTIVE TennCare is continuing the process of reviewing all covered drug classes. Changes to the PDL may occur as new classes are reviewed and previously reviewed classes are revisited. As a result of these changes, some medications your patients are now taking may be considered non-preferred agents in the future. Please inform your patients who are on these medications that switching to preferred products will decrease delays in receiving their medications. We encourage you to share this information with other TennCare providers. The individual changes to the PDL are listed below. A copy of the new PDL will be posted May 1, 2019 for more details on clinical criteria, please visit: Below is a summary of the PDL changes that will be effective May 1, All other agents in these classes will retain their current PDL listing. The following agents available in specific package sizes (e.g. - bottles, tubes, pumps, etc.) will have a quantity limit added: Changes to quantity limits (QL) for the preferred drug list (PDL) effective May 1, 2019: ACANYA GEL PUMP ACULAR LS 0.4% OPHTH SOL ACUVAIL 0.45% OPHTH SOLUTION ACZONE 5% GEL ACZONE 7.5% GEL PUMP ADAPALENE 0.1% CREAM ADAPALENE 0.1% GEL ADAPALENE 0.3% GEL ADAPALENE 0.3% GEL PUMP ADAPALENE-BNZYL PEROX % AK-POLY-BAC EYE OINTMENT ALA-SCALP 2% LOTION ALCLOMETASONE DIPR 0.05% OINT ALCLOMETASONE DIPRO 0.05% CRM ALOCRIL 2% EYE DROPS ALOMIDE 0.1% EYE DROPS ALPHAGAN P 0.1% DROPS ALPHAGAN P 0.15% EYE DROPS ALREX 0.2% EYE DROPS ALTRENO 0.05% LOTION AMCINONIDE 0.1% CREAM AMMONIUM LACTATE 12% CREAM AMMONIUM LACTATE 12% LOTION ANALPRAM HC 2.5%-1% CREAM ANALPRAM HC 2.5%-1% LOTION ANDROGEL 1%(2.5G) GEL PACKET ANDROGEL 1%(5G) GEL PACKET ANDROGEL 1.62% GEL PUMP ANDROGEL 1.62%(1.25G) GEL PCKT ANDROGEL 1.62%(2.5G) GEL PCKT ANUSOL-HC 2.5% CREAM APEXICON E 0.05% CREAM APRACLONIDINE HCL 0.5% DROPS ATOPICLAIR CREAM ATRALIN 0.05% GEL ATROPINE 1% EYE DROPS ATROPINE 1% EYE OINTMENT AVAGE 0.1% CREAM AVAR 9.5%-5% FOAM AVAR LS 10%-2% FOAM AVAR-E EMOLLIENT CREAM AVAR-E LS CREAM AVC 15% CREAM AVITA 0.025% CREAM -Page 1 of 5-
2 AVITA 0.025% GEL CLEOCIN T 1% LOTION AZASITE 1% EYE DROPS CLIND PH-BENZOYL PEROX 1.2-5% AZELASTINE HCL 0.05% DROPS CLINDAGEL 1% GEL AZELEX 20% CREAM CLINDAMYCIN PHOSPHATE 1% FOAM BACITRACIN 500 UNIT/GM OPHTH CLINDAMYCIN-BENZOYL PEROX 1-5% BACTROBAN 2% CREAM CLINDA-TRETINOIN 1.2 % % BENSAL HP 3% OINTMENT CLINDESSE 2% VAGINAL CREAM BENZACLIN GEL 50G PUMP CLOBETASOL 0.05% CREAM BENZAMYCIN GEL CLOBETASOL 0.05% GEL BENZOYL PEROXIDE 5.3% FOAM CLOBETASOL 0.05% OINTMENT BENZOYL PEROXIDE 9.8% FOAM CLOBETASOL 0.05% TOPICAL LOTN BEPREVE 1.5% EYE DROPS CLOBETASOL EMOLLIENT 0.05% CRM BESIVANCE 0.6% SUSP CLOBETASOL EMULSION 0.05% FOAM BETAMETHASONE DP 0.05% CRM CLOBETASOL PROP 0.05% FOAM BETAMETHASONE DP 0.05% LOT CLOCORTOLONE PIVALATE 0.1% CRM BETAMETHASONE DP 0.05% OINT CLODAN 0.05% KIT BETAMETHASONE DP AUG 0.05% CRM CLOTRIMAZOLE 1% CREAM BETAMETHASONE DP AUG 0.05% GEL CLOTRIMAZOLE-BETAMETHASONE CRM BETAMETHASONE DP AUG 0.05% LOT CLOTRIMAZOLE-BETAMETHASONE LOT BETAMETHASONE DP AUG 0.05% OIN COLY-MYCIN S OTIC SUSP DROP BETAMETHASONE VA 0.1% CREAM COMBIGAN 0.2%-0.5% EYE DROPS BETAMETHASONE VA 0.1% LOTION CONDYLOX 0.5% GEL BETAMETHASONE VALER 0.1% OINTM CORTIFOAM 10% AEROSOL BETAMETHASONE VALER 0.12% FOAM CRINONE 4% GEL BETAXOLOL HCL 0.5% EYE DROP CRINONE 8% GEL BETOPTIC S 0.25% EYE DROPS CROMOLYN 4% EYE DROPS BIMATOPROST 0.03% EYE DROPS CROTAN 10% LOTION BIMATOPROST 0.03% EYELASH SOLN CUTIVATE 0.05% CREAM BLEPHAMIDE EYE DROPS CUTIVATE 0.05% LOTION BLEPHAMIDE EYE OINTMENT CYCLOGYL 0.5% EYE DROPS BPO 4% GEL CYCLOGYL 2% EYE DROPS BPO 8% GEL CYCLOMYDRIL EYE DROPS BRIMONIDINE 0.2% EYE DROP CYCLOPENTOLATE 1% EYE DROPS BROMFENAC SODIUM 0.09% EYE DRP CYSTARAN 0.44% EYE DROPS BROMSITE 0.075% EYE DROPS DENAVIR 1% CREAM BRYHALI 0.01% LOTION DENTA 5000 PLUS CREAM BUTENAFINE HCL 1% CREAM DENTAGEL 1.1% GEL CALCIPOTRIENE 0.005% CREAM DERMACINRX PHN PAK CALCIPOTRIENE 0.005% OINTMENT DERMATOP 0.1% OINTMENT CALCIPOTRIENE-BETAMETH DP OINT DERMOTIC OIL 0.01% EAR DROPS CALCITRIOL 3 MCG/G OINTMENT DESONATE 0.05% GEL CARAC 0.5% CREAM DESONIDE 0.05% CREAM CARTEOLOL HCL 1% EYE DROPS DESONIDE 0.05% LOTION CICLODAN 0.77% CREAM DESONIDE 0.05% OINTMENT CICLOPIROX 0.77% GEL DESOXIMETASONE 0.05% CREAM CILOXAN 0.3% OINTMENT DESOXIMETASONE 0.05% GEL CIPRO HC OTIC SUSPENSION DESOXIMETASONE 0.05% OINTMENT CIPROFLOXACIN 0.2% OTIC SOLN DESOXIMETASONE 0.25% CREAM CLEOCIN 2% VAGINAL CREAM DESOXIMETASONE 0.25% OINTMENT CLEOCIN T 1% GEL DEXAMETHASONE 0.1% EYE DROP -Page 2 of 5-
3 DICLOFENAC 0.1% EYE DROPS DICLOFENAC 1.5% TOPICAL SOLN DICLOFENAC SODIUM 3% GEL DIFFERIN 0.1% LOTION DIFLORASONE 0.05% CREAM DIFLORASONE 0.05% OINTMENT DIVIGEL 0.25 MG GEL PACKET DIVIGEL 0.5 MG GEL PACKET DIVIGEL 1 MG GEL PACKET DOXEPIN 5% CREAM DUREZOL 0.05% EYE DROPS ECONAZOLE NITRATE 1% CREAM EFUDEX 5% CREAM ELESTRIN 0.06% GEL ELIDEL 1% CREAM ELLZIA PAK ELOCON 0.1% CREAM ELOCON 0.1% OINTMENT EMADINE 0.05% EYE DROPS ENSTILAR 0.005%-0.064% FOAM EPIDUO FORTE % GEL PUMP EPIFOAM FOAM ERTACZO 2% CREAM ERYGEL 2% GEL ERYTHROMYCIN 0.5% EYE OINTMENT ESTRACE 0.01% CREAM EURAX 10% CREAM EXELDERM 1% CREAM EXTINA 2% FOAM FABIOR 0.1% FOAM FINACEA 15% FOAM FINACEA 15% GEL FLAREX 0.1% EYE DROPS FLUOCINOLONE 0.01% CREAM FLUOCINONIDE 0.05% CREAM FLUOCINONIDE 0.05% GEL FLUOCINONIDE 0.05% OINTMENT FLUOCINONIDE 0.1% CREAM FLUOCINONIDE-E 0.05% CREAM FLUOROMETHOLONE 0.1% DROPS FLURANDRENOLIDE 0.05% OINTMENT FLURBIPROFEN 0.03% EYE DROP FLUTICASONE PROP 0.005% OINT FML FORTE 0.25% EYE DROPS FML S.O.P. 0.1% OINTMENT FORTESTA 10 MG GEL PUMP GATIFLOXACIN 0.5% EYE DROPS GELNIQUE 10% GEL PUMP GENTAK 3 MG/GM EYE OINTMENT GENTAMICIN 0.1% CREAM GENTAMICIN 0.1% OINTMENT GYNAZOLE 1 2% CREAM HALOBETASOL PROP 0.05% CREAM HALOBETASOL PROP 0.05% OINTMNT HALOG 0.1% CREAM HALOG 0.1% OINTMENT HYDROCORT BUTY 0.1% LIPID CRM HYDROCORTISONE 1% CREAM HYDROCORTISONE 1% CREAM HYDROCORTISONE 2.5% CREAM HYDROCORTISONE 2.5% LOTION HYDROCORTISONE 2.5% OINTMENT HYDROCORTISONE BUTY 0.1% CREAM HYDROCORTISONE BUTYR 0.1% LOTN HYDROCORTISONE BUTYR 0.1% OINT HYDROCORTISONE VAL 0.2% CREAM HYDROCORTISONE VAL 0.2% OINTMT HYDROQUINONE 4% CREAM HYDROQUINONE TR 4% CREAM ILEVRO 0.3% OPHTH DROPS IMIQUIMOD 3.75% CREAM PUMP IMIQUIMOD 5% CREAM PACKET IODOQUINOL-HYDROCORT-ALOE GEL IOPIDINE 1% EYE DROPS ISOPTO CARPINE 1% EYE DROPS ISOPTO CARPINE 2% EYE DROPS ISOPTO CARPINE 4% EYE DROPS ISTALOL 0.5% EYE DROPS KERAFOAM 30% FOAM KERAFOAM 42% FOAM KETOCONAZOLE 2% CREAM KETOROLAC 0.5% OPHTH SOLUTION LASTACAFT 0.25% EYE DROPS LEVOBUNOLOL 0.5% EYE DROPS LEVOFLOXACIN 0.5% EYE DROPS LIDOCAINE-HC % GEL LIDOCAINE-HC 3-1% CREAM LIDOCAINE-HYDROCORT 3-2.5% GEL LIDOCAINE-PRILOCAINE CREAM LIDOTRAL 3.88% CREAM LIDOZION 3% LOTION LOPROX 0.77% SUSPENSION KIT LOTEMAX 0.5% EYE DROPS LOTEMAX 0.5% EYE OINTMENT LOTEMAX 0.5% OPHTHALMIC GEL LULICONAZOLE 1% CREAM MAXIDEX 0.1% EYE DROPS -Page 3 of 5-
4 MAXITROL EYE DROPS MAXITROL EYE OINTMENT METIPRANOLOL 0.3% EYE DROPS MICORT HC 2.5% CREAM MICORT-HC 2.5% CREAM MIRVASO 0.33% GEL MIRVASO 0.33% GEL PUMP MOXEZA 0.5% EYE DROPS MOXIFLOXACIN 0.5% EYE DROPS MYDRIACYL 1% EYE DROPS NAFTIFINE HCL 1% CREAM NAFTIFINE HCL 2% CREAM NAFTIN 1% GEL NAFTIN 2% GEL NATACYN EYE DROPS NEO-BACIT-POLY-HC EYE OINTMENT NEOMYC-BACIT-POLYMIX EYE OINT NEOMYCIN-POLY-HC EYE DROPS NEOMYCIN-POLYMYXIN-HC EAR SUSP NEOMYC-POLYM-GRAMICID EYE DROP NEVANAC 0.1% DROPTAINER NITRO-BID 2% OINTMENT NORITATE 1% CREAM NUVESSA VAGINAL 1.3% GEL NYSTATIN 100,000 UNIT/GM CREAM NYSTATIN 100,000 UNIT/GM OINT NYSTATIN-TRIAMCINOLONE CREAM NYSTATIN-TRIAMCINOLONE OINTM ONEXTON 1.2%-3.75% GEL ONEXTON GEL PUMP ORALONE 0.1% PASTE OVACE PLUS 10% CREAM OVACE PLUS 9.8% FOAM OVACE PLUS 9.8% LOTION OXICONAZOLE NITRATE 1% CREAM OXISTAT 1% LOTION PANDEL 0.1% CREAM PANRETIN 0.1% GEL PAREMYD EYE DROPS PHENYLEPHRINE 10% EYE DROPS PHENYLEPHRINE 2.5% EYE DROP PHOSPHOLINE IODIDE 0.125% PICATO 0.015% GEL PICATO 0.05% GEL PLIAGLIS 7%-7% CREAM POLYMYXIN B-TMP EYE DROPS PRAMOSONE 1%-1% OINTMENT PRAMOSONE 2.5%-1% OINTMENT PRED FORTE 1% EYE DROPS PRED MILD 0.12% EYE DROPS PRED-G 1% EYE DROPS PRED-G S.O.P. EYE OINTMENT PREDNICARBATE 0.1% CREAM PREDNISOLONE SOD 1% EYE DROP PROCTOCORT 1% CREAM PROCTOFOAM-HC 1%-1% FOAM PROLENSA 0.07% EYE DROPS PROPARACAINE 0.5% EYE DROPS PROTOPIC 0.03% OINTMENT PROTOPIC 0.1% OINTMENT RECTIV 0.4% OINTMENT REGRANEX 0.01% GEL RENOVA 0.02% CREAM RESTASIS MULTIDOSE 0.05% EYE RETIN-A 0.01% GEL RETIN-A 0.05% CREAM RETIN-A 0.1% CREAM RETIN-A MICRO 0.04% GEL RETIN-A MICRO 0.1% GEL RETIN-A MICRO PUMP 0.04% GEL RETIN-A MICRO PUMP 0.08% GEL RETIN-A MICRO PUMP 0.1% GEL ROSADAN 0.75% CREAM KIT ROSADAN 0.75% GEL KIT SALEX 6% CREAM KIT SALICYLIC ACID 27.5% LIQUID SALICYLIC ACID 6% CREAM SALICYLIC ACID 6% FOAM SALICYLIC ACID 6% GEL SALICYLIC ACID 6% LOTION SALKERA 6% FOAM SANTYL OINTMENT SB HYDROCORTISONE 1% OINTMENT SELENIUM SULFIDE 2.5% LOTION SILVADENE 1% CREAM SIMBRINZA 1%-0.2% EYE DROPS SOD SULFACETAMIDE-SULFUR LOTN SOD SULFACETAMIDE-SULFUR LOTN SORILUX 0.005% FOAM SSS 10-5 FOAM SULFACETAMIDE 10% EYE DROPS SULFACETAMIDE 10% EYE OINTMENT SULFAMYLON 8.5% CREAM SULF-PRED % EYE DROPS SYNALAR 0.025% CREAM SYNALAR 0.025% CREAM KIT SYNALAR 0.025% OINTMENT TARGRETIN 1% GEL TAZAROTENE 0.1% CREAM TAZORAC 0.05% CREAM -Page 4 of 5-
5 TAZORAC 0.05% GEL TAZORAC 0.1% GEL TERCONAZOLE 0.4% CREAM TERCONAZOLE 0.8% CREAM TESTIM 1% (50MG) GEL TESTOSTERONE 12.5 MG/1.25 GRAM TIMOLOL 0.25% EYE DROPS TIMOLOL 0.25% GEL-SOLUTION TIMOLOL 0.5% EYE DROPS TIMOLOL 0.5% GEL-SOLUTION TIMOPTIC 0.25% OCUDOSE DROP TIMOPTIC 0.5% OCUDOSE DROP TOBRADEX EYE DROPS TOBRADEX EYE OINTMENT TOBRADEX ST EYE DROPS TOBRAMYCIN 0.3% EYE DROP TOBREX 0.3% EYE OINTMENT TOLAK 4% CREAM TRIAMCINOLONE 0.025% CREAM TRIAMCINOLONE 0.025% LOTION TRIAMCINOLONE 0.025% OINT TRIAMCINOLONE 0.1% CREAM TRIAMCINOLONE 0.1% LOTION TRIAMCINOLONE 0.1% OINTMENT TRIAMCINOLONE 0.5% OINTMENT TRIANEX 0.05% OINTMENT TRIDERM 0.5% CREAM TRIFLURIDINE 1% EYE DROPS TRI-LUMA CREAM TROPICAMIDE 0.5% EYE DROPS ULTRAVATE 0.05% LOTION UMECTA 40% MOUSSE URAMAXIN 20% FOAM URAMAXIN 45% LOTION URAMAXIN GT 45% KIT URAMAXIN GT 45% PRE-FILLED APP UREA 35% FOAM UREA 40% LOTION UREA 45% NAIL GEL VALCHLOR 0.016% GEL VANIQA 13.9% CREAM VEREGEN 15% OINTMENT XERESE 5%-1% CREAM ZIOPTAN % EYE DROPS ZIRGAN 0.15% OPHTHALMIC GEL ZOVIRAX 5% CREAM ZYCLARA 2.5% CREAM PUMP ZYCLARA 3.75% CREAM ZYLET EYE DROPS TRIANEX 0.05% OINTMENT All of the aforementioned changes, whether preferred or non-preferred, may have additional criteria that control their usage. Any agent noted above with a superscripted PA requires Prior Authorization and any agent noted above with a superscripted QL is subject to Quantity Limits. Please refer to the document Drug Criteria Listing located at: for additional information. Important Phone Numbers: Tennessee Health Connection TennCare Fraud and Abuse Hotline TennCare Pharmacy Program Fax Magellan Pharmacy Support Center Magellan Clinical Call Center Magellan Call Center Fax Helpful TennCare Internet Links: Magellan: TennCare website: Please visit the Magellan TennCare website regularly to stay up-to-date on changes to the pharmacy program. For additional information or updated payer specifications, please visit the Magellan website at: then click on pharmacy and choose program information from the drop down menu. Please forward or copy the information in this notice to all providers who may be affected by these processing changes. Thank you for your valued participation in the TennCare program. -Page 5 of 5-
LABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION
LABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION Added Prior Authorization 7/1/17 CORLANOR 5 MG TABLET Added Prior Authorization 7/1/17 CORLANOR 7.5 MG TABLET Added Prior Authorization 7/1/17
More informationWellCare of South Carolina Preferred Drug List Update
WellCare of South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on August 21,
More informationComparison of representative topical corticosteroid preparations (classified according to the US system)
Comparison of representative topical corticosteroid preparations (classified according to the US system) Potency group* Corticosteroid Vehicle type/form Trade names (United States) Available strength(s),
More information79 C. Michael Davenport Blvd. Suite A Frankfort, KY August 5, Dear Kentucky Medicaid Provider:
79 C. Michael Davenport Blvd. Suite A Frankfort, KY 40601 August 5, 2010 Dear Kentucky Medicaid Provider: Please be advised that the Department for Medicaid Services is making changes to the Kentucky Medicaid
More informationHigh-Cost Drug Exclusions
PHARMACY SERVICES High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at
More informationQuarterly pharmacy formulary change notice
Provider Bulletin June 2017 The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. These changes were reviewed and approved at the first quarter Pharmacy and Therapeutics
More informationThe Medical Letter. on Drugs and Therapeutics
The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:
More informationComparison of representative topical corticosteroid preparations (classified according to the US system)
Comparison of representative topical corticosteroid preparations (classified according to the US system) Potency group* Corticosteroid Vehicle type/form Trade names (United States) Available strength(s),
More informationHigh-Cost Drug Exclusions
PHARMACY SERVICES High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at
More informationHigh-Cost Drug Exclusions
Pharmacy Services High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at
More informationDrug Class Literature Scan: Topical Steroids
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationCLINICAL OPHTHALMIC THERAPEUTIC PHARMACEUTICAL AGENTS (TPA) QUICK REFERENCE GUIDE
F- 15 CLINICAL OPHTHALMIC THERAPEUTIC PHARMACEUTICAL AGENTS (TPA) QUICK REFERENCE GUIDE Assembled by: Tim Maillet, OD, BSc NSAO Practice Innovations Committee Chairperson September 2009 F- 16 Ocular Allergies
More informationAETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on March 1, 2017 Drug Name, Strength, Dosage Form ALFUZOSIN HCL ER 10
More informationPremera Blue Cross Medicare Advantage Plans Pharmacy Policy Updates
Premera Blue Cross Medicare Advantage Plans Pharmacy Policy Updates Most Part D-eligible drugs and drug policies are not effective and administered until Centers for Medicare and Medicaid Services approval
More informationEucrisa. Eucrisa (crisaborole) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.25 Subject: Eucrisa Page: 1 of 6 Last Review Date: September 15, 2017 Eucrisa Description Eucrisa
More informationEucrisa. Eucrisa (crisaborole) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Eucrisa Page: 1 of 7 Last Review Date: June 22, 2018 Eucrisa Description Eucrisa (crisaborole)
More informationTopical Immunomodulators
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Topical Immunomodulators Clinical Edit Information Included in this Document Topical Immunomodulators Elidel and Protopic 0.03%
More informationBlueLink TPA FlexRx Updates
BlueLink TPA FlexRx Updates April 2018 TRADE NAME (generic name) or generic name abacavir sulfate soln 20 mg/ml (base equiv) Generic Addition, generic for ZIAGEN alclometasone dipropionate cream 0.05%
More informationAETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on February 1, 2017 Drug Name, Strength, Dosage Form IVERMECTIN 3 MG TABLET
More informationOTC PRODUCTS. 4 Gama Benzene HCL 0.1% + Proflavine Hermisulphate 0.1% + Cetrimide 0.45% Cream
OTC PRODUCTS SR. No. COMPOSITION Allantoin 0.2% + Dimethicone 1% + Urea 10% + Propylene Glycol 5% + Glyserine 5% + 1 Light Liquid Paraffin 8% Cream (FOOT CREAM) 2 Aquous Cream 3 Cetrimide 0.5% + Chlorhexidine
More informationUnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 2116-3 Program Prior Authorization/Medical Necessity Medications Dupixent (dupilumab) P&T Approval Date 1/2017, 5/2017, 7/2017
More information2016 PRESCRIPTION DRUG LIST UPDATES
2016 PRESCRIPTION DRUG LIST UPDATES Evergreen Health 1 st Quarter Below are key updates to the four-tier EHB Prescription Formulary, effective January 1, 2016. Please consult the full formulary for more
More information2017 Formulary Changes Year to Date
2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or
More informationDrugs That May Be Used by Certain Optometrists
Drugs That May Be Used by Certain Optometrists Approved drugs. (a) Administration and prescription of pharmaceutical agents. Optometrists who are certified to prescribe and administer pharmaceutical agents
More informationCHANGES TO YOUR DRUG LIST
CHANGES TO YOUR DRUG LIST More generics and lower-cost brands to help you stay healthy and save money As your health partner, we want to help you get and stay healthy. That means making sure you have access
More informationEffective for all members on August 1, 2017
August 2017 Pharmacy Formulary Change Notice BlueChoice HealthPlan Medicaid is here to help you stay on top of your health care. We want to tell you about some upcoming changes to your Preferred Drug List
More informationMEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Eye & Ear Anti-Inflammatory Disorders P & T DATE 9/12/2017 THERAPEUTIC CLASS Topical Anti-Inflammatory Agents REVIEW HISTORY
More informationFee-For-Service Pharmacy Provider Notice #182 March 2014 P&T Changes
Fee-For-Service Pharmacy Provider Notice #182 March 2014 P&T Changes July 7, 2014 11013 W. Broad Street Glen Allen, VA 23060 Dear Kentucky Medicaid Provider: Please be advised that the Department for Medicaid
More information84:00. Skin and Mucous Membrane Agents. 84:00 Skin and Mucous Membrane Agents
Skin and Mucous Membrane Agents Skin and Mucous Membrane Agents COMPOUND PRESCRIPTION 00000999119 00000999112 COMPOUND - RETINOIC ACID (TRETINOIN) () MISCELLANEOUS COMPOUND To be used when the compound
More informationMedication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018
Independent licensees of the Blue Cross and Blue Shield Association Medication Policy Manual Policy No: dru493 Topic: Dupixent, dupilumab Date of Origin: March 10, 2017 Committee Approval: March 10, 2017
More information2018 Step Therapy FID 18088
2018 Step Therapy FID 18088 Step Therapy ANTIDEPRESSANTS, SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS LEON 2018 Desvenlafaxine Er Fetzima Fetzima Titration Pack Khedezla Paxil SUSP Pristiq Trintellix
More informationConcentrations and Dilutions INTRODUCTION. L earning Objectives CHAPTER
CHAPTER 6 Concentrations and Dilutions L earning Objectives After completing this chapter, you should be able to: INTRODUCTION Concentrations of many pharmaceutical preparations are expressed as a percent
More informationDrug Formulary Update, April 2017 Commercial and State Programs
Drug Formulary Update, April 2017 Commercial and State Programs Updates to the HealthPartners Commercial and State Program Drug Formularies are listed below. Updates apply to all Commercial groups (PreferredRx,
More informationOphthalmic Medication Review and Update. Scott Ensor, OD, MS Associate Professor Southern College of Optometry
Ophthalmic Medication Review and Update Scott Ensor, OD, MS Associate Professor Southern College of Optometry Financial Disclosures None! About Me Native Memphian 2001 SCO Graduate Primary Care Residency
More information1/1/2019 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS
1/1/2019 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS Effective 1/1/19, Cigna is making changes to our formularies that may impact medication coverage for customers at your pharmacy. We have included a
More informationThe safety and effectiveness of Dupixent in pediatric patients have not been established (1).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.30 Subject: Dupixent Page: 1 of 6 Last Review Date: September 15, 2017 Dupixent Description Dupixent
More informationALLERGIC RHINITIS-NASAL
ALLERGIC RHINITIS-NASAL FLUNISOLIDE Patient needs to have paid claims for any one of the following Step 1 drugs: NasaCort OTC, fluticasone Rx, fluticasone OTC, Budesonide OTC. Prior to filling the Step
More informationGeneric Label Name Drug Strength Dosage Form Example Product (s) MME/Unit ACETAMINOPHEN WITH CODEINE
STATE OF TENNESSEE DEPARTMENT OF FINANCE AND ADMINISTRATION DIVISION OF HEALTH CARE FINANCE AND ADMINISTRATION BUREAU OF TENNCARE 3 Great Circle Road NASHVILLE, TENNESSEE 37243 This notice is to advise
More informationOPHTHALMIC MEDICATIONS
OPHTHALMIC MEDICATIONS Ally Cuddy, PharmD PGY1 Pharmacy Resident September 7, 2017 AMERICAN ACADEMY OF OPHTHALMOLOGY American Academy of Ophthalmology. 2015. CASE #1 TR is a 76 YOM with no significant
More informationBlue Cross and Blue Shield of Minnesota GenRx Formulary Updates
Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates April 2018 TRADE NAME (generic name) or generic name Brand/Generic Description of Change abacavir sulfate soln 20 mg/ml (base equiv) Generic
More informationSTATE OF TENNESSEE DIVISION OF TENNCARE 310 Great Circle Road NASHVILLE, TENNESSEE 37243
1 P a g e STATE OF TENNESSEE DIVISION OF TENNCARE 310 Great Circle Road NASHVILLE, TENNESSEE 37243 This notice is to advise you of information regarding the TennCare Pharmacy Program. Please forward or
More informationMagellan Rx Precision Formulary Formulary Updates First Quarter 2019
Magellan Rx Precision Formulary Formulary Updates First Quarter 2019 The Magellan Rx Management Pharmacy & Therapeutics Committee (P&T) and Value Assessment Committee (VAC) meet periodically to review
More informationMagellan Rx Standard Formulary Formulary Updates First Quarter 2019
Magellan Rx Standard Formulary Formulary Updates First Quarter 2019 The Magellan Rx Management Pharmacy & Therapeutics Committee (P&T) and Value Assessment Committee (VAC) meet periodically to review the
More informationSecretary for Health and Family Services Selections for Preferred Products
Secretary for Health and Family Services Selections for Preferred Products This is a summary of the final Preferred Drug List (PDL) selections made by the Secretary for Health and Family Services based
More informationConnecticut Medicaid P&T Meeting Minutes December 2, 2010
Connecticut Medicaid P&T Meeting Minutes December 2, 2010 The meeting started at 6:34 pm Attendance Present Members: Carl Sherter, MD Peggy Manning Memoli, Pharm D Eric Einstein, MD Charles Thompson, MD
More informationYour prescription benefit updates Formulary Updates - Effective January 1, 2019
Your prescription benefit updates Formulary Updates - Effective January 1, 2019 Medications are grouped by the conditions they treat. Each medication is placed in a tier that shows the amount you will
More informationTHE PEDIATRIC RED EYE (Handout)
THE PEDIATRIC RED EYE (Handout) Ida Chung, OD, MSHE, FCOVD, FAAO Western University College of Optometry Associate Professor/Assistant Dean of Learning 309 E. Second Street, Pomona, CA 91766 Office: 909-938-4140
More informationNetwork Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary
Requesting an Exception to the Formulary You can ask Network Health Insurance Corporation to make an exception to our coverage rules. Generally, we will only approve your request for an exception if alternative
More informationAetna Better Health of Michigan 1333 Gratiot Avenue, Suite 400 Detroit, MI AETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on July 1, 2017 ADAPALENE 0.1% CREAM ADAPALENE 0.1% GEL ATORVASTATIN 10
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE January 22, 2013 SUBJECT EFFECTIVE DATE January 15, 2013 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Drug List (PDL) Update January 15, 2013 Pharmacy Services Vincent D. Gordon, Deputy
More informationMichigan Pharmacy and Therapeutics Committee September 9, 2014 at 6:00 PM Kellogg Center, East Lansing, Michigan
Michigan Pharmacy and Therapeutics Committee September 9, 2014 at 6:00 PM Kellogg Center, East Lansing, Michigan Agenda: Introductions Approval of Minutes of July 8, 2014 Meeting P & T Business Review
More informationTexas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD)
Diagnosis: ATOPIC DERMATITIS (AD) Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD) PATIENT ADVICE: Unfortunately, there is no cure for atopic dermatitis, so
More informationPanel: Practice Pearls from the Pros. Prescription Medication: Office Protocols. Kathy Jones, BSN, RN, CPSN
24TH Annual Meeting Panel: Practice Pearls from the Pros Prescription Medication: Office Protocols Kathy Jones, BSN, RN, CPSN Upon completion of this presentation, the participants will self-report an
More information$4 Prescription Program May 5, 2008
Allergies & Cold and Flu Benzonatate 100mg 14 42 Ceron DM syrup 120ml 360ml Ceron drops* 30ml 90ml Dec-Chlorphen drops* 30ml 90ml Dec-Chlorphen DM syrup* 118ml 354ml Loratadine 10mg 30 90 Promethazine
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Enstilar, Sernivo, Taclonex) Reference Number: CP.CPA.255 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end
More informationWellCare s South Carolina Preferred Drug List Update
WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/03/2015.
More informationMiotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D.
Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Direct agonists Indirect agonist Antagonist Direct agonist: Miosis, accomodation
More information4/24/2018. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D.
Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Direct agonists Indirect agonist Antagonist Direct agonist: Miosis, accomodation Increase
More informationSelect Drug Quantity Management
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationPharmacologic Treatment of Atopic Dermatitis
J KMA Pharmacotherapeutics Pharmacologic Treatment of Atopic Dermatitis Chun Wook Park, MD Department of Dermatology, Hallym University College of Medicine E mail : dermap@paran.com J Korean Med Assoc
More informationDQSA Listening Session June 6, 2017
DQSA Listening Session June 6, 2017 I am Allison Madson, manager of regulatory affairs, for the American Society of Cataract and Refractive Surgery. ASCRS is a medical specialty society representing nearly
More information$4 Prescription Program October 23, 2007
Allergies & Cold and Flu Benzonatate 100mg 14 Ceron DM syrup Ceron drops Dec-Chlorphen drops Dec-Chlorphen DM syrup 118ml* Loratadine 10mg Promethazine DM syrup Trivent DPC syrup * Antibiotic Treatments
More information2018 Formulary Notice of Change Prescription Drug Plans
2018 Formulary Notice of Change Prescription Drug Plans WellCare Prescription Insurance, Inc. Plans in all states: WellCare Classic (PDP) WellCare may add or remove drugs from our formulary during the
More informationDry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj.
Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. 3-Ceftriaxone 250mg & Sulbactam 125mg Inj. 4-Ceftriaxone 125mg & Sulbactam 62.5mg Inj. 5-Rabeprazole
More informationProduct List Finished Dosage Forms (FDF) B2B Business
Product List 2017 Finished Dosage Forms (FDF) B2B Business Anaesthetics Dermatology Lidocaine Lidocaine and Prilocaine Dexmedetomidine Hydrochloride Anti-Infectives Amoxicillin Trihydrate and Potassium
More informationWVCH Formulary Additions Effective 01/01/2016 Name Strength Dosage Form Route Formulary Restrictions
WVCH Formulary Additions Effective 01/01/2016 Name Strength Dosage Form Route Formulary Restrictions ANORO ELLIPTA 62.5-25MCG BLST W/DEV INHALATION ARCAPTA NEOHALER 75 MCG CAP W/DEV INHALATION CALCIPOTRIENE
More informationRemoved from formulary. Removed from formulary. Added to formulary. Quanitity limit changed. Removed from formulary. Removed from formulary
AETNA BETTER HEALTH October 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on October 1, 2017 MIDAZOLAM HCL 5MG/ML VIAL MIDAZOLAM HCL 10 MG/2 ML
More informationChanges to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies
Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies BlueCross BlueShield of South Carolina may add or remove drugs from the formulary during the year. If we remove drugs
More information2018 Step Therapy (ST) Criteria
2018 Step Therapy (ST) Criteria Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a
More informationOHIO MEDICAID PHARMACY COVERAGE
OHIO MEDICAID PHARMACY COVERAGE This information is intended for use by providers to help select the most appropriate cost-effective medication and formulation for their patients. Prescribers should utilize
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Step Therapy Reference Number: HIM.PA.109 Effective Date: 08.01.17 Last Review Date: 05.18 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at the end
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Step Therapy Reference Number: HIM.PA.109 Effective Date: 08.01.17 Last Review Date: 05.18 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at the end
More informationOcular Medication and Compliance
Ocular Medication and Compliance Consultant for Alcon Disclosures CECELIA KOETTING, OD FAAO VIRGINIA EYE CONSULTANTS VOA CONFERENCE NORFOLK 2018 Virginia Optometry License Generic vs Brand Name Every state
More informationPharmaceutical and Therapeutics Committee
Earl Ray Tomblin Governor STATE OF WEST VIRGINIA DEPARTMENT OF HEALTH AND HUMAN RESOURCES Bureau for Medical Services Pharmacy Services 350 Capitol Street Room 251 Charleston, West Virginia 25301-3706
More informationChildren s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
More informationBLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES
BLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES Blue Shield is committed to covering safe, effective and affordable medications, so we regularly review and update our drug formularies.
More informationNeighborhood Medicaid Formulary Changes: June 2017
Neighborhood Medicaid Formulary Changes: June 2017 The following changes to the Neighborhood Medicaid Formulary were recently approved by the Pharmacy and Therapeutics (P&T) Committee. All changes were
More informationADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS
ADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS Cigna will be making additional formulary changes that may impact customers at your pharmacy. We have included a list of drugs by drug class
More informationStep Therapy Medications
Step Therapy Medications Step Therapy (ST PA ) is an automated form of prior authorization. It encourages the use of therapies that should be tried first, before other treatments are covered, based on
More informationDupixent (dupilumab)
Dupixent (dupilumab) Line(s) of Business: HMO; PPO; QUEST Integration Effective Date: TBD POLICY A. INDICATIONS The indications below including FDA-approved indications and compendial uses are considered
More informationOffice of Medicaid Policy and Planning Over-the-Counter Drug Formulary ANALGESICS ANTACIDS ANTI-FLATULENTS
Acetaminophen 80mg/0.8mL Suspension Drops Acetaminophen 120mg Suppository Acetaminophen 160mg/5mL Suspension Acetaminophen 325mg Suppository Acetaminophen 325mg Tablet, Caplet, or Capsule Acetaminophen
More informationNEBRASKA MEDICAID PREFERRED DRUG LIST As of 10/1/09 (See Legend Below Table)
1 NEBRASKA MEDICAID DRUG LIST As of 10/1/09 (See Legend Below Table) Note: Only drugs that are part of the listed therapeutic categories are affected by the Preferred Drug List. More categories will be
More informationCovered and non-covered. Headline. drugs
Covered and non-covered Headline drugs Drugs not covered and their covered alternatives for the Premier and Premier Plus pharmacy plans 2018 Formulary Exclusions Drug List 05.03.925.1 (9/17) aetna.com
More informationCENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 3Q17 July August
BRAND NAME Dupixent GENERIC NAME dupilumab MANUFACTURER Regeneron DATE OF APPROVAL March 28, 2017 PRODUCT LAUNCH DATE First week of April 2017 REVIEW TYPE Review type 1 (RT1): New Drug Review Full review
More information11 Eye. To be used in conjunction with NICE guidance/guidelines, the British National Formulary for adults and/or children, and
11 Eye To be used in conjunction with NICE guidance/guidelines, the British National Formulary for adults and/or children, and The Royal College of Ophthalmologists guidelines Index 11.1 Administration
More informationWellCare s South Carolina Preferred Drug List Update
WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/21/2017.
More informationADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS
ADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS Effective 7/1/2017, Cigna will be making additional formulary changes that may impact customers at your pharmacy. We have included a list of
More informationCommissioner for the Department for Medicaid Services Selections for Preferred Products
Commissioner for the Department for Medicaid Services Selections for Preferred Products This is a summary of the final Preferred Drug List (PDL) selections made by the Commissioner for the Department for
More informationDeveloped by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Joint formulary - Ophthalmology
Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Document type and title: Joint formulary - Ophthalmology Authorised document folder: New or replacing
More informationTennCare Program TN MAC Price Change List As of: 03/30/2017
1 TN List Run : 03/30/17 Old PRAZOSIN HCL 5 MG CAPSULE ORAL 03/29/2017 1.11209 1.12560 ( 1.2) CAPTOPRIL 12.5 MG TABLET ORAL 07/07/2015 1.07191 1.10416 ( 2.9) ISOSORBIDE DINITRATE 5 MG TABLET ORAL 03/29/2017
More informationUWSP Student Health Service Pharmacy Formulary 1/22/2015
UWSP Student Health Service Pharmacy Formulary 1/22/2015 UWSP Student Health Service Pharmacy Formulary 1/22/2015 Medication Name Strength DosageForm Route Acetaminophen 325 MG Tablet Oral Acetaminophen-Codeine
More informationCHANGES TO YOUR DRUG LIST
CHANGES TO YOUR DRUG LIST More generics and lower-cost brands to help you stay healthy and save money At Cigna, it s our goal to offer you access to coverage for safe, effective and affordable medications.
More informationPRESCRIPTION DRUG LIST CHANGES
PRESCRIPTION DRUG LIST CHANGES Cigna Pharmacy Management 2018 The medications listed below are changing coverage (or cost levels) on Cigna s Prescription Drug List. Changes are listed by drug list name
More informationCovered and non-covered drugs
Covered and non-covered drugs Drugs not covered and their covered alternatives for the Premier and Premier Plus pharmacy plans Formulary Exclusions Drug List aetna.com Additional exclusions may apply to
More informationCovered and non-covered drugs
Covered and non-covered drugs Drugs not covered and their covered alternatives for the Premier and Premier Plus pharmacy plans Formulary Exclusions Drug List aetna.com Key January 2019 Formulary Exclusions
More informationPharmacy Benefit Determination Policy
Policy Subject: Atopic Dermatitis Agents Policy Number: SHS PBD18 Category: Policy Type: Medical Pharmacy Department: Pharmacy Product (check all that apply): Group HMO/POS Individual HMO/POS PPO ASO s:
More informationThere have been no updates to the Aetna Better Health of MI formulary for February
AETNA BETTER HEALTH Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on April 1, 2018 Drug Name, Strength, Dosage Form BUTALBIT-ACETAMINOPHEN-CAFF CP CELECOXIB
More informationIHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT NOVEMBER 30, 2010
IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201056 NOVEMBER 30, 2010 Changes to the Preferred Drug List Changes to the Preferred Drug List (PDL) were made at the November 19, 2010, Drug Utilization
More informationCovered and non-covered drugs
Covered and non-covered drugs Drugs not covered and their covered alternatives for the Value and Value Plus pharmacy plans 2018 Formulary Exclusions Drug List 05.03.924.1A (11/17) aetna.com Additional
More information